GINKGO BIOWORKS HOLDINGS INC

AlphaGenome, Google DeepMind’s 30‑times larger AI model, promises a multi‑level genomic insight that could reshape biology, biotech investment, and AI safety debate.

Vitruvian by Nucleus Genomics promises up to a 14‑point IQ boost in embryos— but at $20k‑$50k and amid ethical debate, is this genetic upgrade truly worth the cost?

Intelligence costs are plummeting—dropping ~50% quarterly, faster than DNA, compute, or batteries—while AI models launch faster, sparking debate on local AI in everyday devices.

Explore how transhumanist theory shifts the AI debate from “Humans vs. AI” to human‑technology integration and the challenges that may delay the rise of Homo Evolutis.

DeepMind’s AlphaGenome Atlas maps 9 billion DNA mutations, offering AI‑driven impact scores for non‑coding variants that speed discovery and clinical insight.